{
  "id": "62507602e764a5320400000d",
  "type": "factoid",
  "question": "What does temsirolimus inhibit?",
  "ideal_answer": "Temsirolimus is a mTOR inhibitor",
  "documents": [
    "http://www.ncbi.nlm.nih.gov/pubmed/34804848",
    "http://www.ncbi.nlm.nih.gov/pubmed/31331862",
    "http://www.ncbi.nlm.nih.gov/pubmed/34589671",
    "http://www.ncbi.nlm.nih.gov/pubmed/34565342"
  ],
  "snippets": [
    {
      "text": "a clinically relevant mTOR inhibitor, temsirolimus,",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/34565342",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "e mTOR-inhibitor temsirolimus ",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/34589671",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "mTOR inhibitors: 23 everolimus and 21 temsirolimus;",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/31331862",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Temsirolimus is a mTOR inhibitor approved for the first-line treatment of advanced or metastatic renal cell carcinoma (a/mRCC) with poor prognosis.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/34804848",
      "beginSection": "abstract",
      "endSection": "abstract"
    }
  ],
  "concepts": [],
  "exact_answer": "mTOR"
}